These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36052140)

  • 1. Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study.
    Ceccanti M; Libonati L; Ruffolo G; Cifelli P; Moret F; Frasca V; Palma E; Inghilleri M; Cambieri C
    Front Pharmacol; 2022; 13():982434. PubMed ID: 36052140
    [No Abstract]   [Full Text] [Related]  

  • 2. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.
    Oh SJ; Claussen GG; Hatanaka Y; Morgan MB
    Muscle Nerve; 2009 Nov; 40(5):795-800. PubMed ID: 19722254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in neuromuscular transmission in myasthenia gravis by 3,4-diaminopyridine.
    Lundh H; Nilsson O; Rosén I
    Eur Arch Psychiatry Neurol Sci; 1985; 234(6):374-7. PubMed ID: 2992990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
    Sanders DB; Massey JM; Sanders LL; Edwards LJ
    Neurology; 2000 Feb; 54(3):603-7. PubMed ID: 10680790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of low frequency repetitive nerve stimulation in patients with myasthenia gravis and its correlation with clinical features].
    He XT; Wang LJ; Chen JL; Xie CG; Gan R; Yang R
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2443-2447. PubMed ID: 34399557
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.
    Onesti E; Frasca V; Ceccanti M; Tartaglia G; Gori MC; Cambieri C; Libonati L; Palma E; Inghilleri M
    CNS Neurol Disord Drug Targets; 2019; 18(3):232-238. PubMed ID: 30706796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-diaminopyridine treatment for Lambert-Eaton myasthenic syndrome in adults: a meta-analysis of randomized controlled trials.
    Zhang N; Hong D; Ouyang T; Meng W; Huang J; Li M; Hong T
    BMC Neurol; 2021 Sep; 21(1):371. PubMed ID: 34563155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution characteristics and correlation analysis of antibody detection value in myasthenia gravis].
    Liu YL; Zheng YM; Luo JJ; Zhang W; Gao F; Yuan Y; Hao HJ
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3221-3226. PubMed ID: 31694116
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    J Physiol; 2013 May; 591(10):2747-62. PubMed ID: 23440963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Severity Assessment and Short-Term Outcome in Patients with Myasthenia Gravis.
    Vemuri D; Garuda BR; Gopi S; Kumar TS; Kumari UA
    Ann Indian Acad Neurol; 2020; 23(2):215-219. PubMed ID: 32189865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.
    Marcuse F; Brandts L; Moens D; Damoiseaux J; Hochstenbag M; Hoeijmakers JGJ; Maessen JG; De Baets M
    Eur J Neurol; 2022 Apr; 29(4):1187-1197. PubMed ID: 34967067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study.
    Dos Santos A; Noury JB; Genestet S; Nadaj-Pakleza A; Cassereau J; Baron C; Videt D; Michel L; Pereon Y; Wiertlewski S; Magot A
    Eur J Neurol; 2020 Nov; 27(11):2277-2285. PubMed ID: 32526053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Rituximab in Refractory Generalized anti-AChR Myasthenia Gravis.
    Landon-Cardinal O; Friedman D; Guiguet M; Laforêt P; Heming N; Salort-Campana E; Jouen F; Allenbach Y; Boyer O; Chatenoud L; Eymard B; Sharshar T; Benveniste O
    J Neuromuscul Dis; 2018; 5(2):241-249. PubMed ID: 29865089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.
    Rodríguez Cruz PM; Palace J; Ramjattan H; Jayawant S; Robb SA; Beeson D
    Neurology; 2015 Sep; 85(12):1043-7. PubMed ID: 26296515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palpebral portion of the orbicularis oculi muscle to repetitive nerve stimulation testing: A potential assessment indicator in patients with generalized myasthenia gravis.
    Yan C; Song J; Pang S; Yi F; Xi J; Zhou L; Ding D; Wang W; Qiao K; Zhao C
    J Clin Neurosci; 2018 Feb; 48():238-242. PubMed ID: 29239825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.
    Katyal N; Narula N; Govindarajan R
    J Neuromuscul Dis; 2021; 8(2):287-294. PubMed ID: 33325394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome.
    Lee MK; Sunwoo IN; Kim SM
    J Clin Neurosci; 2018 Apr; 50():194-198. PubMed ID: 29402568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of electromyography in 111 patients with generalized myasthenia gravis: a retrospective study].
    Lin ZZ; Ran H; Chen P; Deng J; Huang ZD; Ou CY; Qiu L; Feng HY; Liao SJ; Liu WB
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2522-2526. PubMed ID: 31484280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.